第 43 卷第 2 期 |  | Vol. 43 No. 2 | 2013 年 4 月 | Apr 2013 |
|
所屬欄目:醫藥及中間體
鹽酸替羅非班的合成研究 |
劉 超,陸旭芳,耿元碩,李志裕*
(中國藥科大學(xué) 藥物化學(xué)教研室,江蘇 南京 210009) |
摘 要:以4-(4-哌啶基)-1-氯丁烷、L-酪氨酸等為原料經(jīng)過(guò)7步反應得到鹽酸替羅非班。此合成路線(xiàn)操作簡(jiǎn)易,總收率達21.6%,中間體及最終產(chǎn)物結構均經(jīng)過(guò)MS和1H NMR確證。 |
關(guān)鍵詞:血小板GP IIb/IIIa 受體拮抗劑;鹽酸替羅非班;合成 |
中圖分類(lèi)號:R737.902 文獻標識碼:A 文章編號:1009-9212(2013)02-0042-04 |
|
Synthesis of Tirofiban Hydrochloride |
LIU Chao,LU Xu-fang,GENG Yuan-shuo,LI Zhi-yu*
(Department of Medicinal Chemistry,China Pharmaceutical University,Nanjing 210009,China) |
Abstract:Tirofiban hydrochloride is a reversible non-peptide platelet GP IIb/IIIa receptor antagonist,for the treatment of acute coronary syndrome. This paper reported the synthesis of Tirofiban hydrochloride from 4-(4-piperidinyl)-1-chlorobutane and L-tyrosine via 7 steps of chemical reactions. This new synthesis route with low-toxicity and simple operation has a high yield which is up to 21.6%. The structures of the intermediates and the final product were certified by MS and 1H NMR. |
Key words:platelet GP IIb/IIIa receptor antagonist;Tirofiban hydrochloride;synthesis |
|
作者簡(jiǎn)介:劉 超(1987-),男,內蒙古呼和浩特人,碩士研究生,主要從事藥物活性分子的設計與合成。(E-mail:chaosliu21@163.com)
|
聯(lián) 系 人:李志裕,教授,碩士研究生導師。(E-mail:zhiyuli@cpu.edu.cn)
|
收稿日期:2013-04-23
|
|